The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) holds a meeting on the hepatitis B vaccine and childhood vaccine schedule changes at 8 a.m. ET on Dec. 4.
Schedule:
8 a.m. Welcome, Roll Call, and Opening Statement
Dr. Robert Malone (ACIP vice chair)
Dr. Mina Zadeh (ACIP executive secretary)
8:30 a.m. Hepatitis B—Recap
Dr. Robert Malone (ACIP vice chair)
Policy Context and Schedule Comparison Dr. Vicky Pebsworth (ACIP childhood and adolescent immunization schedule workgroup chair) Burden of Disease Dr. Cynthia Nevison (Presenter)
HBV Vaccine Safety Mr. Mark Blaxill (CDC) Discussion (ACIP members and ex officios) Discussion (Liaisons)
10:40 a.m. Hepatitis B Vaccine Manufacturers Dr. Candice Robinson (GSK)
Dr. Michelle Goveia (Merck)
Dr. Ayman Chit (Sanofi)
Q&A (ACIP members, ex-officios, liaisons)
11:05 a.m. Lunch
11:35 a.m. Hepatitis B Vaccines (continued)
Summary of the Information and Presentation of the Vote Language
Dr. Vicky Pebsworth (ACIP childhood and adolescent immunization schedule workgroup chair)
VFC Presentation Dr. Jeanne Santoli (CDC)
CMS Comments Mr. Andrew Johnson (CMS, ACIP ex officio)
Discussion (ACIP members and ex officios)
Discussion (Liaisons)
1:50 p.m. Perspectives from People with Lived Experience
2 p.m. Public Comments
2:30 p.m. Votes
Dr. Robert Malone (ACIP vice chair)
Hepatitis B Vaccine
Hepatitis B Vaccine—VFC
3:15 p.m. Coverage Implications
VFC Comments Dr. Jeanne Santoli (CDC)
CMS Comments Mr. Andrew Johnson (CMS, ACIP ex officio)
3:25 p.m. Break
3:30 p.m. Update on Work Groups Dr. Robert Malone (ACIP vice chair)
3:35 p.m. Agency Updates CDC, CMS, FDA, HRSA, IHS, NIH
3:45 p.m. Adjourn
